JFL Life Sciences Limited (NSE: JFLLIFE)

Market Cap	813.33M
Revenue (ttm)	465.50M
Net Income (ttm)	33.10M
Shares Out	33.00M
EPS (ttm)	1.00
PE Ratio	24.57
Forward PE	n/a
Dividend	0.08 (0.34%)
Ex-Dividend Date	Sep 13, 2024

Volume	6,000
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	36.05 - 68.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About JFL Life Sciences

JFL Life Sciences Limited engages in the manufacture and sale of pharmaceutical products in India and internationally. It offers B-Lactam dry powder injections, and solid oral dosage form tablets and capsules; general solid oral dosage form tablets and capsules; and oral rehydration solutions. The company was incorporated in 2010 and is headquartered in Ahmedabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 2010
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: JFLLIFE

Financial Performance

In 2023, JFL Life Sciences's revenue was 465.50 million, an increase of 8.69% compared to the previous year's 428.30 million. Earnings were 33.10 million, an increase of 17.79%.